NCT03626922 2022-06-10
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
NSABP Foundation Inc
Phase 1 Unknown
NSABP Foundation Inc
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
The First Hospital of Jilin University
Endocyte
Endocyte
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company